Pregabalin Capsule
Product Images NDC 71335-2343

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71335-2343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713352343)

Label (Lbl713352343)
Each capsule contains 100 mg of Pregabalin. These capsules are used for medication. The National Drug Code (NDC) for this product is 71335-2343-1. It is important to keep this medication and all drugs out of reach from children. The capsules should be stored at a temperature of 25°C (77°F), with excursions permitted to 15° to 30°C (59° to 86°F) as specified by the USP Controlled Room Temperature guidelines. The medication should be dispensed in a tight, child-resistant container. Each package contains 30 capsules. The medication has been repackaged by Bryant Ranch Prepack, Inc. and manufactured by StieGen Pharmaceuticals, Inc. For more information, refer to the Medication Guide provided by the manufacturer.*
FDA Label Image

Figure 1 (Pregabalin Fig01)

Figure 1 (Pregabalin Fig01)
FDA Label Image

Figure 2 (Pregabalin Fig02)

Figure 2 (Pregabalin Fig02)
FDA Label Image

Figure 3 (Pregabalin Fig03)

Figure 3 (Pregabalin Fig03)
FDA Label Image

Figure 4 (Pregabalin Fig04)

Figure 4 (Pregabalin Fig04)
FDA Label Image

Figure 5 (Pregabalin Fig05)

Figure 5 (Pregabalin Fig05)
FDA Label Image

Figure 6 (Pregabalin Fig06)

Figure 6 (Pregabalin Fig06)
FDA Label Image

Figure 7 (Pregabalin Fig07)

Figure 7 (Pregabalin Fig07)
FDA Label Image

Figure 9 (Pregabalin Fig08)

Figure 9 (Pregabalin Fig08)
FDA Label Image

Figure 10 (Pregabalin Fig09)

Figure 10 (Pregabalin Fig09)
FDA Label Image

Figure 11 (Pregabalin Fig10)

Figure 11 (Pregabalin Fig10)
The text appears to be a data table showing the percentage of subjects who improved from baseline to week 12 in two different treatments (Pregetalin and Placeso). However, the text is not entirely clear and some characters are not readable. Therefore, a complete and accurate description cannot be generated.*
FDA Label Image

Figure 12 (Pregabalin Fig11)

Figure 12 (Pregabalin Fig11)
This text provides information about the percent of subjects who improved from baseline to week 16 in a study comparing the effects of Pregabalin and Placebo. The percent improvement is shown for different values ranging from 100 to 280.*
FDA Label Image

Figure 13 (Pregabalin Fig13)

Figure 13 (Pregabalin Fig13)
This text appears to be a table showing responder rates for different treatments. The first column shows the "Responder Rate (%)" values, and the subsequent columns show different percentages. There is a column labeled "Placebo" with the values "2.5 mglkglday" and "10 mg/kglday". The last row appears to show some numerical values, possibly related to the responder rates. The information provided is limited, but it seems to be related to a medical or clinical study.*
FDA Label Image

Cockcroft And Gault Equation (Pregabalin Formula)

Cockcroft And Gault Equation (Pregabalin Formula)
This is a formula that calculates CLCT (Creatinine Clearance) based on age, weight, and serum creatinine levels. The calculation involves subtracting the age in years (in this case, indicated as 140) from weight in kilograms, and then multiplying it by a factor of 0.85 for female patients. The result is then multiplied by 72 and the serum creatinine level in mg/dL.*
FDA Label Image

Chemical Structure (Pregabalin Str)

Chemical Structure (Pregabalin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.